I've Reached a $1 Million Net Worth – Should I Get Umbrella Coverage?
SmartAsset and Yahoo Finance LLC may earn commission or revenue through links in the content below.
With a question about umbrella coverage, your net worth doesn’t much apply. The question is more about what you need in order to protect yourself, your assets and your family. That has more to do with your exposure and risk of loss than with how much you have to lose. As to whether someone would need umbrella insurance in this scenario, the answer is truly a “maybe.” It depends on your current insurance coverage, the costs of extra coverage and the specific risks you’re concerned about.
Do you have questions about financial planning? Speak with a financial advisor today.
Umbrella insurance is a secondary policy that kicks in after your primary insurance policy is exhausted. It covers any losses or payouts beyond the coverage of your primary insurance.
For example, say that you have an auto insurance policy that covers up to $150,000 in liability and damages. You are considered at-fault in an auto accident with a driver who suffers $95,000 worth of damage to their car and $155,000 worth of personal injuries and lost wages.
Your insurance policy could pay for the first $150,000 of this claim. Then, an umbrella insurance policy could pay that remaining $100,000 for which you would otherwise be personally liable.
The main reason to buy umbrella insurance is third-party liability. By and large, you can know in advance the value of your own property and assets, whether personal or real estate. Since this is knowable, you can buy insurance to cover most cases of personal loss.
Liability is another matter. It’s impossible to predict with any certainty the value of a third party’s assets or injuries. You might be in a car accident someday, or accidentally injure a guest at a party. Since accidents are impossible to predict, so are the costs and harms associated with them. This is where umbrella insurance comes in, as it covers you in case of unpredictable liability that exceeds your policy’s coverage.
Most consumers who get umbrella insurance will use it to supplement either auto or homeowner’s policies. Typically you must have an existing primary insurance policy, as this will not act as your main insurance. For homeowners, this can supplement coverage that you get based on your personal needs and mortgage requirements. For drivers, this can supplement coverage that you have based on your personal needs and your state minimum coverage laws. A financial advisor can help you review and coordinate your current coverage.
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Metagenomi, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGX
NEW YORK, Oct. 27, 2024 (GLOBE NEWSWIRE) —
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of Metagenomi, Inc. MGX pursuant and/or traceable to the Company’s initial public offering conducted between February 9 and 13, 2024 (the “IPO”), of the important November 25, 2024 lead plaintiff deadline.
SO WHAT: If you purchased Metagenomi stock you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Metagenomi class action, go to https://rosenlegal.com/submit-form/?case_id=29254 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 25, 2024. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, Metagenomi introduced itself to investors during its IPO as a “genetic medicines company” having a long-standing business relationship with Moderna, one of the leading Covid-19 vaccine companies. Integral to Metagenomi’s collaboration with Moderna was the claim that the two companies had entered into a Strategic Collaboration and License Agreement on October 29, 2021, which included multiple four-year research programs and a subsequent licensed product-by-licensed product agreement. Metagenomi completed its initial public offering on February 13, 2024, selling 6.25 million shares at $15 per share. However, less than three months later, on May 1, 2024, Metagenomi announced that it and Moderna had “mutually agreed to terminate their collaboration” agreement. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Metagenomi class action, go to https://rosenlegal.com/submit-form/?case_id=29254 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
case@rosenlegal.com
www.rosenlegal.com
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
The Best High-Yield Oil Stock to Invest $1,000 in Right Now
If you are looking at oil and natural gas stocks, there is one thing you should go in expecting — and that’s volatility. Oil prices are known to swing dramatically and, often, quickly. Any investor putting money to work, whether it be $100, $1,000, or $100,000, has to be prepared for periods of weakness because they will, eventually, arrive. Which is why buying an industry leader like Chevron (NYSE: CVX) is probably the best choice for most investors. Here’s what you need to know.
There are companies that drill for oil and natural gas, which make up the upstream segment of the oil industry. There are companies that transport oil and natural gas, and the products into which they get turned, via energy infrastructure assets like pipelines that comprise the midstream segment of the energy sector. And there are companies that refine and process oil and natural gas and turn them into things like gasoline and chemicals in the downstream segment of the industry.
Then there are companies that do all of that, with assets spread across the entire energy landscape. These are the integrated energy companies, a group that includes Chevron. The reason to do this is that each of the different segments of the energy industry performs differently at different times. The best example is that low oil prices will hurt the upstream business but often benefit the downstream business, which uses oil as an input. For most investors, owning an integrated energy company will be the best option in the energy sector.
Chevron competes with companies like ExxonMobil, BP, Shell, and TotalEnergies. However, if you are looking for an integrated oil company, Chevron stands out in some important ways.
Shell and BP both cut their dividends during the peak of the coronavirus pandemic. Although they have high yields, those dividend cuts will likely bother income investors looking for reliable dividend stocks. TotalEnergies didn’t cut its dividend, but it has been increasingly investing in electricity and renewable power assets. While it is changing with the world around it, as cleaner energy options grow in importance, it really isn’t a pure-play energy company anymore. That leaves Exxon and Chevron, both of which have stuck closer to their oil roots. And both of which have a long history of increasing their dividend year in and year out.
To be fair, Exxon’s 42-year streak of annual dividend increases is better than Chevron’s 37-year streak. But both streaks are impressive when you consider the huge swings in the price of oil and natural gas that have occurred over the past three decades. So, really, Chevron stands toe to toe with Exxon on this front. But it beats Exxon in two other important areas.
Inside Trump's Inner Circle: How JD Vance-Backed Tech Magnate Pavlovski Is Shaping Up Right-Wing Politics
In the aftermath of Donald Trump’s ban from major social media platforms, tech entrepreneur Chris Pavlovski emerged as a significant ally. The CEO of Rumble Inc. RUM, a video-streaming platform, Pavlovski integrated himself into Trump’s inner circle, providing essential technical support to Trump Media & Technology Group Corp DJT, which operates Truth Social, per a report by The Washington Post.
Pavlovski’s Rise In Conservative Politics
Pavlovski’s connections with Trump deepened during a 2021 meeting at Mar-a-Lago, where he mingled with Trump’s staff. His expertise was pivotal in establishing Rumble’s cloud infrastructure for Truth Social, marking Rumble as a key player in Trump’s media strategy. This partnership became crucial as Trump’s digital presence relied heavily on alternative platforms due to perceived censorship by mainstream tech companies, the Post added.
Also Read: Elon Musk Pumps More Than $130M Into Trump And GOP Campaigns
Rumble, initially launched as a competitor to YouTube, gained traction among conservative users frustrated with content moderation during the pandemic. Backed by a group of conservative investors, including JD Vance, Rumble received a vital $25 million investment in 2021, the report read. This financial boost coincided with Rumble’s significant growth, culminating in its public offering in 2022, which valued the company over $2 billion.
However, Pavlovski’s international hiring practices, particularly in North Macedonia, have raised eyebrows given Trump’s “America First” rhetoric. Despite employing local workers, some critics argue this approach contradicts promises to bring jobs back to the U.S. Pavlovski’s recent discussions with North Macedonia’s government suggest potential expansion of Rumble’s services abroad, further entrenching the company’s role in conservative politics.
Rumble as a Haven for Right-Wing Content
As Rumble continues to host controversial content, including state-sponsored propaganda, it has become a haven for users seeking less moderation. Pavlovski has positioned himself at the forefront of right-wing media, with Trump’s family increasingly integrating into Rumble’s ecosystem, The Washington Post reported.
Pavlovski recently visited North Macedonia with Devin Nunes, CEO of Trump Media, to meet with the country’s right-wing government. They discussed the possibility of Rumble providing cloud services to the Macedonian government similar to those it offers for Trump’s Truth Social. Recently, Pavlovski was seen with Ivanka Trump and Jared Kushner at a UFC fight and dined with Donald Trump Jr. and Kimberly Guilfoyle.
Pavlovski’s rise within conservative circles underscores the growing intersection of technology and politics, particularly with the election just a couple of weeks away.
His partnership with Trump and platforms like Rumble could significantly shape the political landscape as they navigate the upcoming election.
Read Next:
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trump's Rising Election Odds Sends Emerging Markets Into Tailspin, Causes Biggest Stock Drop In 10 Months
The odds of a Donald Trump victory seem to be having a significant impact on emerging market stocks, which are seeing their worst monthly drop since January.
What Happened: The potential implementation of Trump’s proposed tariff plan is causing concern. A recent report has highlighted a four-day consecutive fall in the MSCI Emerging Markets Index. This marks a 3.1% decline this month.
Major companies such as Samsung, Alibaba, Tencent, and Meituan have been hit hardest, accounting for over half of the index’s fall.
According to the report by Markets Insider, with the election just a fortnight away, the market is increasingly factoring in a Trump win.
On the crypto betting market Polymarket, Trump’s odds of winning rocketed to 66% on Tuesday, the highest since President Joe Biden was still in the running in July. These odds have since slightly decreased to 62%.
Trump’s proposed tariff plan, which suggests raising tariffs on imports from all countries up to 20% and imposing a 60% tariff on imports from China, has ignited investor fears of a detrimental trade war.
Also Read: Donald Trump Takes Betting Market Lead Over Kamala Harris Following RFK Jr.s’ Exit
Citi bank analysts have noted that the election’s outcome is driving investors to pull away from emerging market shares due to the growing uncertainty.
Other factors such as escalating geopolitical tensions in the Middle East and a bond market sell-off are also pushing investors to steer clear of riskier assets.
Why It Matters: The potential return of Trump’s aggressive trade policies is causing unease among investors. His proposed tariff plan could lead to a damaging trade war, particularly with China, which would likely have a negative impact on global trade.
This, combined with other factors such as rising geopolitical tensions and a bond market sell-off, is causing investors to shy away from riskier assets, including emerging market stocks.
The uncertainty surrounding the election outcome is only adding to these concerns.
Read Next:
This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
In this election cycle, ‘bond vigilantes’ are voting too—and they don’t like what they see
Suburban moms, crypto bros, and Swifties aren’t the only voters making their presence felt this election season. Bond investors are voting with their dollars in financial markets, and they don’t like what they see.
The term “bond vigilantes” was famous coined by Wall Street veteran Ed Yardeni in the 1980s, referring to traders who protested massive deficits by selling off bonds to push yields higher.
In a note published Wednesday, Yardeni, who is president of Yardeni Research, and Eric Wallerstein, the firm’s chief markets strategist, wrote that the vigilantes are voting early and pointed to the 10-year Treasury yield soaring by 63 basis points to 4.25% since the Federal Reserve announced a half-point rate cut at its meeting last month.
“In exit polls, the Bond Vigilantes are saying they are voting against Fed Chair Jerome Powell’s dovish monetary policy because the economy is running hot, and the Fed’s premature 50bps rate cut on September 18 raises the risk that it will overheat,” they said.
Treasury yields tumbled ahead of the first rate cut as investors looked for an aggressive easing cycle to match the aggressive tightening cycle. Since the Fed meeting, however, they’ve staged a big reversal.
Sentiment has turned so much that some Wall Street forecasters have warned that the central bank may even pause on further cuts. That’s as Fed officials and economic data have dampened optimism for lots of easing.
In their note, Yardeni and Wallerstein also attributed recent market moves to the outlook for federal deficits, which have ballooned recently and hit $950 billion in the fiscal year that ended Sept. 30, up 35% from the prior year due mostly to higher rates.
“The Bond Vigilantes may also be voting against Washington, figuring that no matter which party wins the White House and the Congress, fiscal policies will bloat the already bloated federal government budget deficit and heat up inflation,” they explained. “The next administration will face net interest outlays of over $1 trillion on the ballooning federal debt.”
Budget watchdogs have warned on the exploding federal deficit. While it will expand under either Donald Trump or Kamala Harris, the Penn Wharton Budget Model and the Committee for a Responsible Federal Budget have said Trump’s policies would produce a much deeper hole.
That’s as the former president has teased a range of tax cuts and even eliminating income taxes altogether. Meanwhile, his vow to hike tariffs across the board is also widely seen as inflationary because companies typically pass along the added costs to consumers in the form of higher prices.
Billionaire Ken Griffin Just Increased His Position in This Dividend Stock by 5,848%. Here's Why Now May Be a Great Time to Buy.
Ken Griffin is a billionaire hedge fund manager and serves as CEO to Citadel Advisors. According to Citadel’s most recent 13F filing, the firm bought 18,736,591 shares of Kenvue (NYSE: KVUE) stock during the second quarter — increasing its position by 5,848%.
Below, I’m going to break down why now could be a lucrative time to scoop up shares of Kenvue. More importantly, I’ll assess the company’s full picture and make the case for why this consumer health business could be a great long-term buy for the right investor.
Although you may not be familiar with Kenvue by name, I suspect you’re well aware of the company’s leading health brands. Kenvue is the business behind brands such as Aveeno, Listerine, Zyrtec, Tylenol, Motrin, Benadryl, Neosporin, Neutrogena, Nicorette, Band-Aid, and so much more.
As flu season nears, Kenvue may witness some seasonal high demand levels for its over-the-counter allergy and cold treatments.
Kenvue is a spin-off from Johnson & Johnson and has only been trading as a stand-alone entity for a little more than a year. Despite its limited trading activity, I think the table below outlining Citadel’s position in Kenvue over the last year could help shed light on a couple of important themes.
Category |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
---|---|---|---|---|---|
Shares owned |
6.6 million |
2.6 million |
2.4 million |
320,000 |
19.1 million |
Data source: Hedge Follow.
According to public filings, Citadel bought 6.6 million shares of Kenvue around the time of its initial public offering. But until the second quarter of this year, Griffin and his team had been net sellers of Kenvue stock.
What could possibly inspire such a massive purchase after several consecutive periods of selling?
For starters, Kenvue stock is down roughly 15% since going public and currently trades at a forward price-to-earnings (P/E) multiple below that of the S&P 500. It’s possible that Citadel views Kenvue as a mispriced opportunity and thinks the market is overlooking a potential run-up in the stock following flu season. With that in mind, I would not be surprised if Citadel sees Kenvue as more of a trade and not a position with long-term conviction.
But to be fair, Citadel also bought shares in several other consumer staples or healthcare-adjacent opportunities during the second quarter. For example, the fund increased positions in Pfizer, UnitedHealth Group, Clorox, and Humana.
It’s entirely possible that Citadel bought Kenvue as a hedge against other opportunities in its diverse portfolio.
3 Dividend Growth Stocks You Can Buy and Hold Forever
In the immortal words of the late, great entertainer Prince, forever “is a mighty long time.” For investors, though 15 to 20 years can practically feel like forever. It can be hard to find stocks you’ll feel comfortable holding onto for that long.
However, three Motley Fool contributors think they’ve identified excellent dividend growth stocks you can buy and hold forever (or at least, the investing version of forever): Abbott Laboratories (NYSE: ABT), AbbVie (NYSE: ABBV), and Johnson & Johnson (NYSE: JNJ).
David Jagielski (Abbott Laboratories): When you’re looking for good dividend growth stocks to hold for years or even decades, start by looking for businesses with diverse revenue streams and excellent track records of increasing their payouts. Healthcare giant Abbott Laboratories checks off both of those boxes for investors.
At the current share price, its dividend yields just 1.8%, which may look unimpressive at first. However, the company has increased its payouts for 52 consecutive years, making it a Dividend King. Moreover, Abbott has been paying dividends steadily for a century, with its first payment taking place back in 1924. Along the way, the company has delivered dividends to its shareholders despite wars, inflation, economic downturns, and a lot of other turbulence.
Over the past decade, Abbott has increased its quarterly payout by 150%, from $0.22 in 2014 to $0.55 today. The only reason the healthcare stock’s yield isn’t higher now is because its valuation rose by more than 180% over that same period. When including dividend reinvestment, the total return investors would have achieved from owning shares of Abbott for the past 10 years is around 250%.
Abbott has a slow-and-steady growing healthcare business, and has many opportunities it can pursue. Its growth rate isn’t massive, but it is sustainable. And with multiple segments, including pharmaceuticals, diagnostics, medical devices, and nutrition, its operations look solid. Excluding the impact of its COVID-19 testing business, the company is projecting organic sales growth of around 10% this year.
For long-term dividend investors, this could be an ideal stock to buy and forget about.
Keith Speights (AbbVie): If you like Abbott, you might love AbbVie. The big drugmaker spun off from Abbott in 2013. Since then, it has increased its dividend by a whopping 288%. Thanks to the time it was part of Abbott, AbbVie also qualifies as a Dividend King. At the current share price, its forward dividend yield is 3.3%.
Goldman says the party's over, Tesla stock soars, and Microsoft's Bitcoin bet: Markets news roundup
The stock market party is over, Goldman Sachs says
The era of double-digit growth in the stock market may be coming to an end.
Goldman Sachs (GS) strategists led by David Kostin estimate that the S&P 500 index will deliver an annualized return of 3% over the next decade — well below the 13% returns in the last 10 years and the long-term average of 11%.
The Dow drops 250 points as McDonald’s stock slumps with Tesla earnings up next
The Dow Jones Industrial Average and other major indexes opened lower on Wednesday as the yield on the benchmark 10-year U.S. Treasury note continued its upward climb, reaching 4.23%—a level not seen since July. However, there was some relief for investors as oil prices eased, with West Texas Intermediate (WTI) futures trading around $70.65 per barrel.
Crypto is getting hammered today and Bitcoin has dropped to $65,000
The cryptocurrency market is experiencing a downturn, closely mirroring the decline in the stock market. On Wednesday, Bitcoin saw a significant drop of over 2.5% in the past 24 hours, with its price hovering around $65,000. This decline has dashed hopes of breaking the $70,000 threshold, which had gained traction just a week prior. The downward trajectory underscores the growing volatility in the crypto market and highlights the interconnectedness between cryptocurrencies and traditional financial markets.
The Dow drops 200 points but the Nasdaq pops after Tesla’s blockbuster earnings
It was a mixed day for investors, as the Dow dropped over 200 points and the Nasdaq jumped after Tesla’s better-than-expected earnings report. In the afternoon, the Dow dropped 203 points, or 0.4%, to 42,311. Meanwhile, the Nasdaq and S&P 500 popped up 0.6% and 0.1%, respectively.
The SEC greenlit Bitcoin ETF options trading. Here come the big fish
The Securities and Exchange Commission (SEC) has granted approval for the NYSE American LLC and CBOE to list options on spot Bitcoin exchange-traded funds (ETFs), marking a significant development in cryptocurrency history. This approval paves the way for institutional investors, or “big fish,” to gain greater access to Bitcoin through more traditional financial products.
The Dow closes 400 points lower, marking its worst performance in more than a month
The Dow Jones Industrial Average and other major indexes suffered a steep decline on Wednesday as the yield on the benchmark 10-year U.S. Treasury note continued its upward climb, reaching 4.23%—a level not seen since July.
Dogecoin, ApeCoin, Solana, and more: Cryptocurrencies to watch
The crypto market is currently bullish, with growing anticipation around when bitcoin will surpass the $70,000 mark. And coming tech earnings reports could further boost the overall market sentiment.
Betting on Bitcoin? Microsoft’s shareholders will decide soon
Microsoft (MSFT) will soon determine whether to invest in Bitcoin, although the board has recommended voting against the proposal, citing that the company already considers a wide range of investable assets, including Bitcoin.
Expect the stock market ‘fear index’ to spike heading into the election, strategist says
A contested election could cause volatility in the stock market. Peter Repetto, investment strategist at iCapital, breaks down what investors can expect
GM earnings could be a great sign for Tesla and the Magnificent 7, strategist says
Peter Repetto, investment strategist at iCapital, breaks down what GM’s big earnings beat means
Bitcoin Analyst Predicts New Highs Amid Market Stagnation: 'We Are Right On Track, Right On Schedule'
Bitcoin’s BTC/USD price trajectory has been a topic of keen interest, and now, after King Crypto’s sideways movement over the past few weeks, an analyst believes that it is headed for a new all-time high.
What Happened: Analyst Kevin Svenson forecasts a potential surge to new all-time highs. He suggests that the apex crypto is poised for a significant breakout, drawing on historical patterns to support his prediction.
Svenson thinks that Bitcoin could soon enter a highly explosive phase of its market cycle.
He highlights that after Bitcoin’s first halving in 2012, it took around 41 months to surpass the previous all-time high. Similarly, following the second halving in 2016, it took about 36 months.
Bitcoin is currently 35 months past its last all-time high, indicating a potential breakout.
“We are right on track, right on schedule. There is nothing wrong with the cycle timing. The only thing that was wrong this cycle is people’s expectation that once Bitcoin touched a new all-time high, that it had to begin trending above the all-time high,” he said.
Svenson suggests Bitcoin could begin trading above its current all-time high of $74,000 as early as next month, based on these historical trends.
“There were past cycles like in 2016 where we touched the all-time high, but it took another month or two to begin trending above the all-time high. So we’re really on track.”
Why It Matters: Bitcoin’s price has been relatively subdued, trading at $67,900, a modest 1.2% gain, despite reaching near $69,000 earlier in the week. The leading cryptocurrency currently sits 8% below its all-time high of $73,737.
Earlier, Bitcoin experienced a brief surge to an intraday high of $68,693 before dipping below $68,000 on profit-taking.
Moreover, optimism surrounds Bitcoin’s future, with Matt Hougan, Chief Investment Officer of Bitwise, projecting a six-figure price by 2025. He cited factors such as the recent halving event in April, which reduced miners’ rewards by half, significantly influencing Bitcoin’s market dynamics.
Price Action: At the time of writing, Bitcoin was trading at $67,063, rising marginally by 0.30% in the last 24 hours, according to Benzinga Pro data.
Read Next:
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Pixabay
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.